포스파티딜콜린 시장 : 기회, 성장 동인, 산업 동향 분석 및 예측(2024-2032년)

The Global Phosphatidylcholine Market garnered USD 1.3 billion in 2023 and will grow at 6% CAGR from 2024 to 2032, spurred by heightened consumer awareness of health and wellness coupled with advancements in pharmaceutical applications and a growing demand for dietary supplements. As individuals increasingly prioritize their health, they seek effective supplements that support cognitive function, liver health, and overall well-being. Moreover, advancements in research and technology are expanding the applications of phosphatidylcholine in pharmaceuticals, enhancing its therapeutic potential. This convergence of health consciousness and innovative applications positions phosphatidylcholine as a key ingredient in the evolving wellness landscape.

The phosphatidylcholine industry is segmented based on source, form, application, and region.

The soybean segment held USD 578.3 million in 2023 and will expand at a 6.5% CAGR during 2024-2032, driven by its widespread availability and cost-effectiveness. Soybean-derived phosphatidylcholine is favored for its established applications in dietary supplements and pharmaceuticals, making it a popular choice among manufacturers. As health-conscious consumers increasingly seek affordable and effective supplements, the demand for soybean-based products continues to rise. Besides, the growing emphasis on non-GMO and allergen-free ingredients further enhances the appeal of soybean phosphatidylcholine, solidifying its dominant position in the market.

The pharmaceuticals segment was expanded to USD 477.3 million in 2023 and gain a 6.8% CAGR from 2024 to 2032, fueled by its critical role in various therapeutic applications. Phosphatidylcholine is recognized for its high purity and effectiveness in formulations targeting liver health, cognitive function, and cell membrane integrity. As the demand for innovative drug delivery systems increases, phosphatidylcholine's ability to enhance bioavailability and stability makes it a preferred ingredient among pharmaceutical manufacturers. Also, ongoing research and development efforts are likely to expand its applications, reinforcing its prominence in the pharmaceutical segment.

North America phosphatidylcholine industry accumulated USD 470.1 million in 2023 and will grow at a 6.5% CAGR till 2032, fueled by a growing emphasis on health and wellness among consumers. The region's strong pharmaceutical sector drives demand for high-quality phosphatidylcholine in various therapeutic applications, including dietary supplements and functional foods. Additionally, increasing awareness of the ingredient's benefits for liver health and cognitive function further boosts its popularity. With a robust regulatory framework supporting clean-label products, North America remains a significant contributor to the overall growth of the phosphatidylcholine market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Base estimates and calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Key manufacturers
  • 3.1.2 Distributors
  • 3.1.3 Profit margins across the industry
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Market challenges
  • 3.2.3 Market opportunity
    • 3.2.3.1 New opportunities
    • 3.2.3.2 Growth potential analysis
• 3.3 Raw material landscape
  • 3.3.1 Manufacturing trends
  • 3.3.2 Technology evolution
    • 3.3.2.1 Sustainable manufacturing
      • 3.3.2.1.1 Green practices
      • 3.3.2.1.2 Decarbonization
  • 3.3.3 Sustainability in raw materials
  • 3.3.4 Pricing trends (USD/Ton), 2021 - 2032
    • 3.3.4.1 North America
    • 3.3.4.2 Europe
    • 3.3.4.3 Asia Pacific
    • 3.3.4.4 Latin America
    • 3.3.4.5 Middle East and Africa
• 3.4 Regulations and market impact
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)

• 5.1 Key trends
• 5.2 Soybean
• 5.3 Sunflower
• 5.4 Egg Yolk
• 5.5 Rapeseed
• 5.6 Others (mustard and cottonseed)

Chapter 6 Market Size and Forecast, By Form, 2021-2032 (USD Million, Tons)

• 6.1 Key trends
• 6.2 Liquid
• 6.3 Powder
• 6.4 Granules

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)

• 7.1 Key trends
• 7.2 Pharmaceuticals
• 7.3 Dietary supplements
• 7.4 Cosmetics and personal care
• 7.5 Food and beverages
• 7.6 Others (animal nutrition and industrial application)

Chapter 8 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 MEA
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 South Africa
  • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

• 9.1 Amitex Agro Product Pvt. Ltd.
• 9.2 Creative Biolabs
• 9.3 Croda International Plc
• 9.4 Fengchen Group Co., Ltd
• 9.5 Lipoid GmbH
• 9.6 Merck KGaA
• 9.7 MITUSHI BIO PHARMA
• 9.8 Rajvi Enterprise
• 9.9 SimSon Pharma Limited